Anbio Biotechnology (NNNN) vs Alpha Teknova (TKNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Alpha Teknova (TKNO) has outperformed Anbio Biotechnology (NNNN) over the past year, gaining 66.2% versus a loss of 83.4%. Alpha Teknova is the larger company by market cap ($467.6 million vs $215.1 million), about 2.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NNNN | TKNO |
|---|---|---|
| Share price | $4.90 | $8.71 |
| Market cap | $215.07M | $467.62M |
| 1-day change | 0.00% | -0.46% |
| YTD return | -83.70% | +129.21% |
| 1-year return | -83.37% | +66.22% |
| 5-year return | — | -62.29% |
| P/E ratio (TTM) | 32.67 | — |
| EPS (TTM) | $0.15 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $44.73 | $9.48 |
| 52-week low | $4.66 | $1.91 |
| Distance from 52-week high | -89.05% | -8.12% |
| Average volume | 147.22K | 232.52K |
| Shares outstanding | 43.89M | 53.69M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alpha Teknova is about 2.2 times larger than Anbio Biotechnology by market value ($467.62M vs $215.07M).
- TKNO has outperformed NNNN by 149.6 percentage points over the past year.
NNNN vs TKNO FAQ
Which is bigger, Anbio Biotechnology or Alpha Teknova?
Alpha Teknova (TKNO) is larger, with a market capitalization of $467.62M compared with $215.07M for Anbio Biotechnology (NNNN).
Which stock has performed better over the past year, NNNN or TKNO?
TKNO returned +66.22% over the past 12 months, compared with -83.37% for NNNN (price return, excluding dividends). Past performance does not predict future results.
Are Anbio Biotechnology and Alpha Teknova in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.